Bharat Parenterals Preferential Issue (1 Oct 2026)
Bharat Parenterals Limited seeks approval for Rs. 138,99,95,043.15 preferential issue
Bharat Parenterals · Pharmaceuticals & Biotechnology
Key highlights
- Board approved on September 29, 2026, issuance of up to 9,12,759 equity shares at Rs. 1522.85 each via preferential issue
- Investment in subsidiaries up to Rs. 135,00,00,000 and general corporate purposes up to Rs. 3,99,95,043.15, within 2 years of receipt of funds
- EGM on October 23, 2026 at 11:30 a.m. through VC/OAVM; remote e-voting October 20-22, 2026
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Intimation For Extra-Ordinary General Meeting Of The Company To Be Held On Friday, October 23, 2026.
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Engineering Services
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Bharat Parenterals
- Fundraise / allotmentNotableBharat Parenterals Limited announces shareholder approval of two special resolutions
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentDev Labtech VentureDev Labtech Venture Ltd receives BSE in-principle approval for convertible warrants issue
- Fundraise / allotmentGoldkart JewelsGoldkart Jewels Limited proposes preferential issue of 41.5 lakh convertible warrants
- Fundraise / allotmentPaisalo DigitalPaisalo Digital Limited approves allotment of 1.85 crore equity shares on FCCB conversion
- Fundraise / allotmentVedant FashionsVedant Fashions Limited appoints CFO Vineet Poddar and grants 96,328 stock options
- Fundraise / allotmentVedant FashionsVedant Fashions files board meeting outcomes including CFO appointment and stock options grant
- Fundraise / allotmentTIPCO Engineering IndiaTipco Engineering India Ltd approves share capital increase, acquisitions, and warrants issue
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.
